
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>COVID-19. HHS agencies’ planned reviews of vaccine distribution and communication efforts should include stakeholder perspectives : report to congressional committees</dc:title>
  <dc:title>HHS agencies’ planned reviews of vaccine distribution and communication efforts should include stakeholder perspectives</dc:title>
  <dc:subject>United States. Department of Health and Human Services</dc:subject>
  <dc:subject>COVID-19 Vaccines -- supply &amp; distribution</dc:subject>
  <dc:subject>Government Regulation</dc:subject>
  <dc:description>Why GAO did this study. Vaccination remains critical in the federal response to the COVID-19 pandemic. Vaccine implementation— prioritizing, allocating, distributing, and administering doses—requires coordination among federal, state, and local levels and other stakeholders. HHS agencies—including CDC and HRSA—set up federal vaccine distribution programs, such as CDC’s retail pharmacy program that sends doses directly to pharmacies. The federal government also sends vaccine doses to states for further distribution. The CARES Act includes a provision for GAO to report on its ongoing monitoring and oversight efforts related to the COVID-19 pandemic. This report examines (1) stakeholder perspectives on federal programs to distribute and administer COVID-19 vaccines, (2) efforts to inform health officials, providers, and the public about vaccination, and (3) actions HHS agencies are taking to evaluate their vaccine implementation efforts. GAO reviewed data and documents from HHS, CDC, and HRSA, and reviewed information from and interviewed state and local health officials in four states and one city selected, in part, for geographic variation. GAO also interviewed other stakeholders, including 12 national associations representing health care providers and others. What GAO Recommends. GAO is making four recommendations, including that CDC and HRSA obtain input from and share lessons learned with key stakeholders as they conduct their future reviews. HHS concurred with GAO’s recommendations.</dc:description>
  <dc:publisher>Washington, DC : United States Government Accountability Office, November 2021</dc:publisher>
  <dc:contributor>United States. Government Accountability Office, issuing body.</dc:contributor>
  <dc:contributor>United States. Congress, issuing body.</dc:contributor>
  <dc:type>Technical Report</dc:type>
  <dc:format>Text</dc:format>
  <dc:format>Illustrations</dc:format>
  <dc:format>1 online resource (1 PDF file (iii, 62 pages))</dc:format>
  <dc:identifier>nlm:nlmuid-9918383083806676-pdf</dc:identifier>
  <dc:identifier>9918383083806676</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/9918383083806676</dc:identifier>
  <dc:language>English</dc:language>
  <dc:coverage>United States</dc:coverage>
  <dc:rights>The National Library of Medicine believes this item to be in the public domain. https://creativecommons.org/publicdomain/mark/1.0</dc:rights>
</oai_dc:dc>